<DOC>
	<DOCNO>NCT01635439</DOCNO>
	<brief_summary>The purpose study compare safety efficacy two agent use induction labor Propess ( Controlled release dinoprostone , PGE2 , pessary ) Prostin E2 ( Dinoprostone vaginal Tablet ) .</brief_summary>
	<brief_title>Prostin Propess Induction Labor</brief_title>
	<detailed_description>A controlled release hydrophilic matrix ( Controlled Therapeutics Ltd. , East Kilbride , Scotland ) provide gradual release dinoprostone ( prostaglandin E2 ) introduce 1995 ( Propess , Ferring Pharmaceuticals ) . This preparation use initiation enhancement cervical ripen woman term singleton pregnancy cephalic presentation . Prostaglandin E2 cause soften dilatation cervix subsequently produce uterine contraction may induce labour .</detailed_description>
	<mesh_term>Labor Pain</mesh_term>
	<mesh_term>Dinoprostone</mesh_term>
	<criteria>Gestational age 37 week Singleton pregnancy Cephalic presentation . Previous cesarean section Any contraindication vaginal delivery Suspected CephaloPelvic Disproportion Unexplained antepartum Hemorrhage</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>January 2014</verification_date>
</DOC>